MRK
$MRK
Merck & Co., Inc.
Global pharmaceutical leader known for Keytruda cancer immunotherapy and vaccines.
HealthcareSubscribers
1
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
This week's analysis
MRK: Defensive Pharma with Growth & Income
Merck ($MRK) combines a strong oncology franchise, high ROE, and a durable dividend with a favorable analyst consensus. Near-term catalysts and attractive valuation create upside, though policy and patent risks merit close monitoring.
Apr 6, 2026